These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Müller HK; Kellerer M; Ermel B; Mühlhöfer A; Obermaier-Kusser B; Vogt B; Häring HU Diabetes; 1991 Nov; 40(11):1440-8. PubMed ID: 1657668 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors such as staurosporine, H-7 or polymyxin B cannot be used in skeletal muscle to prove the role of protein kinase C on insulin action. Gumà A; Muñoz P; Camps M; Testar X; Palacín M; Zorzano A Biosci Rep; 1992 Oct; 12(5):413-24. PubMed ID: 1290805 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of H-7, H-8 and polymyxin B on liver protein kinase C-induced phosphorylation of endogenous substrates. Pugazhenthi S; Mantha SV; Khandelwal RL Biochem Int; 1990; 20(5):941-8. PubMed ID: 2161662 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase C inhibitors eliminate hippocampal long-term potentiation. Lovinger DM; Wong KL; Murakami K; Routtenberg A Brain Res; 1987 Dec; 436(1):177-83. PubMed ID: 2825923 [TBL] [Abstract][Full Text] [Related]
8. The isoquinoline sulfonamide inhibitors of protein phosphorylation, H-7, H-8, and HA-1004, also inhibit RNA synthesis: studies on responses of adipose tissue to growth hormone. Goodman HM; Tai LR; Chipkin SR Endocrinology; 1990 Jan; 126(1):441-50. PubMed ID: 1688412 [TBL] [Abstract][Full Text] [Related]
9. Blockade of the spinal excitatory effect of cAMP on the startle reflex by intrathecal administration of the isoquinoline sulfonamide H-8: comparison to the protein kinase C inhibitor H-7. Boulis NM; Davis M Brain Res; 1990 Aug; 525(2):198-204. PubMed ID: 2174710 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase C blocks two components of LTP persistence, leaving initial potentiation intact. Colley PA; Sheu FS; Routtenberg A J Neurosci; 1990 Oct; 10(10):3353-60. PubMed ID: 2213144 [TBL] [Abstract][Full Text] [Related]
11. Postsynaptic protein kinase C essential to induction and maintenance of long-term potentiation in the hippocampal CA1 region. Wang JH; Feng DP Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2576-80. PubMed ID: 1557361 [TBL] [Abstract][Full Text] [Related]
12. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor. Bergstrand H; Lundquist B; Karabelas K; Michelsen P J Pharmacol Exp Ther; 1992 Mar; 260(3):1028-37. PubMed ID: 1372047 [TBL] [Abstract][Full Text] [Related]
13. Effects of protein kinase C activators and inhibitors on membrane properties, synaptic responses, and cholinergic actions in CA1 subfield of rat hippocampus in situ and in vitro. Agopyan N; Agopyan I Synapse; 1991 Mar; 7(3):193-206. PubMed ID: 1882329 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event. Steele TA; Brahmi Z J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683 [TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide alters suckling rat liver glycogenolysis. Goto M; Zeller WP; Picken M; Goto MP; Hurley RM Circ Shock; 1993 May; 40(1):53-60. PubMed ID: 8324890 [TBL] [Abstract][Full Text] [Related]
17. Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. Williams B; Schrier RW J Clin Invest; 1993 Dec; 92(6):2889-96. PubMed ID: 8254044 [TBL] [Abstract][Full Text] [Related]
18. Calcium-dependent protein kinase activity is decreased in diabetic rat sciatic nerve. Gabbay RA; Siconolfi-Baez L; Lebovitz HE Endocrinology; 1990 Sep; 127(3):1194-8. PubMed ID: 2387254 [TBL] [Abstract][Full Text] [Related]
19. Absence of the Staub-Traugott effect in endotoxicosis. Inaba H; Filkins JP Circ Shock; 1991 Aug; 34(4):398-404. PubMed ID: 1773482 [TBL] [Abstract][Full Text] [Related]
20. K252a, a potent protein kinase inhibitor, improves endotoxic lethality and glucose dyshomeostasis. Inaba H; Numai T; Araki M; Mizuguchi T Surg Today; 1993; 23(3):234-40. PubMed ID: 8467175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]